Keywords: halozyme, reduces, iop, animals, san, diego, usa-based

Halozyme reduces IOP in animals

Article | 16 May 2005

Print This

San Diego, USA-based Halozyme Therapeutics says that animal trials of its recombinant human PH20 (rHuPH20) hyaluronidase enzyme are encouraging.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in